ESC 365 - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Open Access

Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Session: Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Topic: Chronic Heart Failure

Sponsored by AstraZeneca

Event: ESC Asia with APSC & AFC 2020

Congress Presentation

1 more presentation in this session

Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Speaker: Professor C. Chiang (Taipei, TW) Associate Professor J. Tan (Singapore, SG)

Access the full session

Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Speakers: Professor C. Chiang, Associate Professor J. Tan

About the event

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Congress

ESC 365 is supported by